SEARCH

SEARCH BY CITATION

References

  • 1
    Ojo AO, Heinrichs D, Emond JC et al. Organ donation and utilization in the USA. Am J Transplant 2004; 4(Suppl 9): 2737.
  • 2
    Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 2003; 9: 651663.
  • 3
    Ploeg RJ, D'Alessandro AM, Knechtle SJ et al. Risk factors for primary dysfunction after liver transplantation—a multivariate analysis. Transplantation 1993; 55: 807813.
  • 4
    Workgroup on expanded criteria organs for liver transplantation. Liver Transpl 2005; 11: 11841192.
  • 5
    Feng S, Goodrich NP, Bragg-Gresham JL et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783790.
  • 6
    Ruhl CE, Everhart JE. Epidemiology of nonalcoholic fatty liver. Clin Liver Dis 2004; 8: 501519, vii.
  • 7
    Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 7679.
  • 8
    Trends in aging—United States and worldwide. MMWR Morb Mortal Wkly Rep 2003;52: 101104, 106.
  • 9
    World Health Organization. Physical status: The use and interpretation of anthropometry, Geneva, Switzerland . World Health Organization Technical Report Series 1995.
  • 10
    Kimm SY, Obarzanek E. Childhood obesity: A new pandemic of the new millennium. Pediatrics 2002; 110: 10031007.
  • 11
    Kahen TSJ, Lavine J, Stanley C, Behling C. Population prevalence of pediatric fatty liver disease. Gastroenterology 2004; 126: A-753.
  • 12
    Afonso RC, Saad WA, Parra OM, Leitao R, Ferraz-Neto BH. Impact of steatotic grafts on initial function and prognosis after liver transplantation. Transplant Proc 2004; 36: 909911.
  • 13
    Ploeg RJ, D'Alessandro AM, Hoffmann RM et al. Impact of donor factors and preservation on function and survival after liver transplantation. Transplant Proc 1993; 25: 30313033.
  • 14
    Briceno J, Marchal T, Padillo J, Solorzano G, Pera C. Influence of marginal donors on liver preservation injury. Transplantation 2002; 74: 522526.
  • 15
    Hoofnagle JH, Lombardero M, Zetterman RK et al. Donor age and outcome of liver transplantation. Hepatology 1996; 24: 8996.
  • 16
    Piratvisuth T, Tredger JM, Hayllar KA, Williams R. Contribution of true cold and rewarming ischemia times to factors determining outcome after orthotopic liver transplantation. Liver Transpl Surg 1995; 1: 296301.
  • 17
    Fernandez-Merino FJ, Nuno-Garza J, Lopez-Hervas P et al. Impact of donor, recipient, and graft features on the development of primary dysfunction in liver transplants. Transplant Proc 2003; 35: 17931794.
  • 18
    Tisone G, Manzia TM, Zazza S et al. Marginal donors in liver transplantation. Transplant Proc 2004; 36: 525526.
  • 19
    Mor E, Klintmalm GB, Gonwa TA et al. The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation 1992; 53: 383386.
  • 20
    Koepsell TD, Weiss NS. Epidemiological Methods. New York , NY : Oxford University Press, 2003: 206208.
  • 21
    National Center for Health Statistics. CDC: Ten leading causes of death by age group, United States—2001. http://www.chdl.org/Projects/10%20Leading%20Causes%20of%20Death%20by%20Age%20Group%202001.pdf. Accessed Aug 10, 2006.
  • 22
    Cameron A, Busuttil RW. AASLD/ILTS transplant course: Is there an extended donor suitable for everyone? Liver Transpl 2005; 11: S2S5.